The technology at the base of INOFEA consists in designing recognition platforms on the basis of a core particle, on which various chemical building blocks are assembled to produce a recognition site.

1. Recognition Nanomaterials
Recognition nanomaterials
with strong added‐value

2. Company overview
Swiss-based high-tech spin-off
Founded in 2001
Specialize in nanomaterials
Trusted partner in research programs
ABOUT US
INOFEA is a Swiss high-tech spin-off based in Basel. INOFEA designs, develops, produces,
and commercializes a set of innovative nanomaterials with remarkable recognition properties
to be embedded in high-value industrial applications and products. From reusable nano-im-
mobilized enzymes to silica-based virus imprints, INOFEA can design efficient solutions for
industrial requirements.
Among the many strengths that distinguish INOFEA
in the marketplace are our:
Extensive expertise in recognition nanomaterials;
Major pilot customers in Switzerland and Europe;
Proprietary technology to produce our nanobiocatalysts at the industrial scale;
High-value products that can streamline our client’s industrial processes;
History of technology innovation and implementation, including our research and development
capabilities, on which we invest annually.
Experienced researchers and advisors in our team.
OUR SPECIALISTS INDUSTRIES WE SERVE
Alessandro Cumbo, biotechnologist from the Pulp and Paper Industry
University of Palermo in Italy, is completing his Industrial wastewater
Ph.D. focusing on the development of the virus Textile Industry
recognition nanomaterial. He is also the scien- Food and Beverage Industry;
tific manager of INOFEA. Energy and Utilities
Green Chemistry
INOFEA benefits from strategic scientific advis-
ing from Professors Corvini and Shahgaldian at
the School for Life Sciences of the FHNW.

3. Our products
The technology at the base of INOFEA consists in designing recogni-
tion platforms on the basis of a core particle, on which various chemical
building blocks are assembled to produce a recognition site. Our prod-
ucts are designed to be embedded in and drastically improve industrial
processes dedicated to the detection, removal or transformation of target
compounds in complex conditions.
Our line of products consists of:
Is a formulation of laccase immobilized onto non-toxic nanoma-
terial, which remains very active in harsh environments.
Is an enzyme used to remove lactose from milk during the pro-
duction of lactose-free dairy products. The product is still in the
development stage.
Is a virusimprinted particle (VIP). VIRofea is a 400 nm diame-
ter nanoparticle with many virus specific recognition sites. The
product is still in the development stage.
PHARMofea consists of a series of nanomaterials based on a
cyclodextrin core with various building blocks that have inherent
affinity for the target pharmaceutical compounds. The product is
still in the development stage.
BENEFITS OF OUR PRODUCTS
Harsh environments resistance. Our products work at extreme pH or in the presence of metals
and other contaminants
Easily recycled and reused. Our products can enbed a technology for introducing a magnetic
core into the core particle.
Adaptability. Our products are easily embeddable in various industrial solutions: membranes,
reactors, cartridges, microplates, etc.

4. Recognition Nanomaterials
Contact details
Business Development Manager
Dr. Yves Dudal
yves.dudal@inofea.com
www.inofea.com
+41 76 423 1229